These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 34207636)

  • 1. What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease?
    Gaunitz S; Tjernberg LO; Schedin-Weiss S
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical glycoprotein mass spectrometry: The future of disease detection and monitoring.
    Marrero Roche DE; Chandler KB
    J Mass Spectrom; 2024 Sep; 59(9):e5083. PubMed ID: 39162140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in LC-MS/MS-based glycoproteomics: getting closer to system-wide site-specific mapping of the N- and O-glycoproteome.
    Thaysen-Andersen M; Packer NH
    Biochim Biophys Acta; 2014 Sep; 1844(9):1437-52. PubMed ID: 24830338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a combined glycomics and glycoproteomics approach for studying the major glycoproteins present in biofluids: Application to cerebrospinal fluid.
    Goyallon A; Cholet S; Chapelle M; Junot C; Fenaille F
    Rapid Commun Mass Spectrom; 2015 Mar; 29(6):461-73. PubMed ID: 26160412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Technologies for Complex Glycoproteomics and Their Applications to Biology/Disease-Driven Glycoproteomics.
    Narimatsu H; Kaji H; Vakhrushev SY; Clausen H; Zhang H; Noro E; Togayachi A; Nagai-Okatani C; Kuno A; Zou X; Cheng L; Tao SC; Sun Y
    J Proteome Res; 2018 Dec; 17(12):4097-4112. PubMed ID: 30359034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
    Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
    J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial in-solution digestion protocol for mass spectrometry-based glycomics and proteomics analysis.
    Sethi MK; Downs M; Zaia J
    Mol Omics; 2020 Aug; 16(4):364-376. PubMed ID: 32309832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment.
    Schedin-Weiss S; Gaunitz S; Sui P; Chen Q; Haslam SM; Blennow K; Winblad B; Dell A; Tjernberg LO
    FEBS J; 2020 Aug; 287(15):3221-3234. PubMed ID: 31889402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics protocols in glycomics and glycoproteomics.
    Tang H; Mayampurath A; Yu CY; Mechref Y
    Curr Protoc Protein Sci; 2014 Apr; 76():2.15.1-2.15.7. PubMed ID: 24692013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Quantitative Glycomics and Proteomics Combined Purification Strategy.
    Hecht ES; McCord JP; Muddiman DC
    J Vis Exp; 2016 Mar; (109):. PubMed ID: 27023253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in mass spectrometry-based glycoproteomics.
    Frost DC; Li L
    Adv Protein Chem Struct Biol; 2014; 95():71-123. PubMed ID: 24985770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems Glycobiology: Integrating Glycogenomics, Glycoproteomics, Glycomics, and Other 'Omics Data Sets to Characterize Cellular Glycosylation Processes.
    Bennun SV; Hizal DB; Heffner K; Can O; Zhang H; Betenbaugh MJ
    J Mol Biol; 2016 Aug; 428(16):3337-3352. PubMed ID: 27423401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-glycan profile in cortex and hippocampus is altered in Alzheimer disease.
    Gaunitz S; Tjernberg LO; Schedin-Weiss S
    J Neurochem; 2021 Oct; 159(2):292-304. PubMed ID: 32986846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Glycan Profile of Cerebrospinal Fluids from Alzheimer's Disease Patients Using Liquid Chromatography with Mass Spectrometry.
    Cho BG; Veillon L; Mechref Y
    J Proteome Res; 2019 Oct; 18(10):3770-3779. PubMed ID: 31437391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a 96-well plate sample preparation method for integrated N- and O-glycomics using porous graphitized carbon liquid chromatography-mass spectrometry.
    Zhang T; Madunić K; Holst S; Zhang J; Jin C; Ten Dijke P; Karlsson NG; Stavenhagen K; Wuhrer M
    Mol Omics; 2020 Aug; 16(4):355-363. PubMed ID: 32281997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in quantitative glycoproteomics.
    Zhang Y; Yin H; Lu H
    Glycoconj J; 2012 Aug; 29(5-6):249-58. PubMed ID: 22699565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoenzymatic method for glycomics: Isolation, identification, and quantitation.
    Yang S; Rubin A; Eshghi ST; Zhang H
    Proteomics; 2016 Jan; 16(2):241-56. PubMed ID: 26390280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case for protein-level and site-level specificity in glycoproteomic studies of disease.
    Schumacher KN; Dodds ED
    Glycoconj J; 2016 Jun; 33(3):377-85. PubMed ID: 27007620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of Isomeric Glycan Structures by Permethylation and Liquid Chromatography-Mass Spectrometry (LC-MS).
    Cho BG; Banazadeh A; Peng W; Zhao J; Goli M; Gautam S; Hussein A; Mechref Y
    Methods Mol Biol; 2021; 2271():281-301. PubMed ID: 33908015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer's disease brain, serum and cerebrospinal fluid towards potential biomarker discovery.
    Gizaw ST; Ohashi T; Tanaka M; Hinou H; Nishimura S
    Biochim Biophys Acta; 2016 Aug; 1860(8):1716-27. PubMed ID: 26968461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.